-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

SVB Leerink Maintains Outperform on Hologic, Raises Price Target to $85

Benzinga · 01/06/2023 09:05
SVB Leerink analyst Puneet Souda maintains Hologic (NASDAQ:HOLX) with a Outperform and raises the price target from $78 to $85.